Breaking News

Freudenberg Medical Launches LUBRITEQ High-Performance Hydrophilic Coating

The coating is accompanied by a comprehensive suite of associated development and manufacturing services.

Author Image

By: Patrick Lavery

Content Marketing Editor

Freudenberg Medical has launched LUBRITEQ, a new, high-performance hydrophilic coating solution. Alongside this, the company released a comprehensive suite of associated development and manufacturing services.

Benefits of LUBRITEQ

To define LUBRITEQ further, Freudenberg said it is an advanced, ultraviolet (UV)-curable, single-step hydrophilic coating. It will have a wide range of medical device applications and is customizable for optimized performance. The comprehensive services model supports customers through the full product lifecycle, eliminating handoffs between multiple suppliers.

Freudenberg Medical, a global CDMO partner to the biopharma and medical device industries, said LUBRITEQ is now available worldwide.

Consequently, Freudenberg said it is the only hydrophilic coating provider pairing advanced surface chemistry with in-house design and manufacturing capabilities. Together, according to the company, these complementary technologies not only enhance manufacturability but also boast greater productivity and reliability.

Seeking Input on Hydrophilic Coating

However, before entering the hydrophilic coatings market, Freudenberg consulted with customers and industry stakeholders to identify unmet needs. And while technologies have advanced, the company found that the needs of customers were still not being fulfilled.

“We heard consistent feedback that directly shaped our strategy,” said Keith Kiernan, Freudenberg Medical Chief Commercial Officer. “Customers aren’t just looking for a better coating—they’re looking for a better partner to de-risk their product launches.”

Kiernan said the company deliberately attempted to create a solution and partnership model reflecting those concerns. “No royalties, no rigidity—just coating performance, partnership and progress,” he said.

Other Freudenberg Moves

News of the new coating followed Freudenberg Medical’s ribbon-cutting of a new production facility in Costa Rica. That became official, realizing a $25 million investment, in late September 2025.

At the time, plans were to double the site’s area—from 50,000 to 100,000 square feet—in three years.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters